Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 7

Results For "Head"

1956 News Found

Foundation S: Sanofi’s new philanthropic spearhead
Sustainability | May 04, 2022

Foundation S: Sanofi’s new philanthropic spearhead

Foundation S will incorporate as its cornerstone initiative the former Sanofi Espoir Foundation’s ‘My Child Matters’ program in childhood cancer


Mylab launches RT-PCR test for Ankylosing Spondylitis ahead of the World AS Day
Medical Device | May 04, 2022

Mylab launches RT-PCR test for Ankylosing Spondylitis ahead of the World AS Day

This RT-PCR diagnostic kit helps in diagnosis of AS by detecting HLAB27 gene


Dr Reddy’s appoints Amit Golash as Global Head-Customer Service & Logistics
People | April 22, 2022

Dr Reddy’s appoints Amit Golash as Global Head-Customer Service & Logistics

He has extensive leadership experience across supply chain and has worked at companies such as Unilever, Flipkart, Colgate-Palmolive & Mondelez


Arrowhead Pharmaceuticals initiates study of ARO-C3
News | February 19, 2022

Arrowhead Pharmaceuticals initiates study of ARO-C3

AROC3-1001 is a phase 1/2, placebo controlled, dose-escalating study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of ARO-C3


Crysta IVF onboards Dr. Neeta Jain as Head, Clinic Operations
People | February 15, 2022

Crysta IVF onboards Dr. Neeta Jain as Head, Clinic Operations

She holds a Masters degree in Genetics along with a Ph.D. in Biochemistry


Quantori names Arun Nayar as Global Head of R&D Informatics
People | January 26, 2022

Quantori names Arun Nayar as Global Head of R&D Informatics

New role strengthens Quantori’s global leadership position in data science & digital IT


Merck KGaA appoints Global R&D Head & CSO for healthcare business sector
People | January 13, 2022

Merck KGaA appoints Global R&D Head & CSO for healthcare business sector

Danny Bar-Zohar will become Global Head of R&D and Joern-Peter Halle will become Chief Strategy Officer


Arrowhead Pharmaceuticals enters agreement with GSK to develop NASH drug candidate
Biotech | November 24, 2021

Arrowhead Pharmaceuticals enters agreement with GSK to develop NASH drug candidate

Arrowhead to receive US $ 120 million upfront payment for Phase 1/2 program for NASH and is eligible to receive potential milestone payments and royalties on commercial sales


Vital Strategies India appoints L. M. Singh as MD, India and Global Head, Partnerships and Innovative Finance
People | November 24, 2021

Vital Strategies India appoints L. M. Singh as MD, India and Global Head, Partnerships and Innovative Finance

In his new role as Managing Director India and Global Head, Partnerships and Innovative Finance, Singh will oversee the financial, human, and operational functions of the India office


WHO gives its go-ahead for first-ever malaria vaccine
Drug Approval | October 07, 2021

WHO gives its go-ahead for first-ever malaria vaccine

It recommends using the vaccine to prevent the spread of the disease